STOCK TITAN

Adapthealth (AHCO) Stock News, Nov 2021-May 2022

AHCO Nasdaq

Welcome to our dedicated page for Adapthealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on Adapthealth stock.

AdaptHealth Corp. reports developments tied to its healthcare-at-home business, which provides home medical equipment, medical supplies and related services. The company’s updates commonly address its Sleep Health, Respiratory Health, Diabetes Health and Wellness at Home categories, including sleep therapy equipment and supplies for obstructive sleep apnea, respiratory services, diabetes-related supplies and in-home wellness offerings.

Recurring AdaptHealth news also covers quarterly and annual results, financial guidance, patient census trends, digital patient engagement through myApp, referral and payor relationships, capitated partnerships, acquisitions and dispositions, credit facility activity, debt ratings and investor conference participation. The company serves Medicare, Medicaid and commercial insurance beneficiaries through a national operating network.

Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) announced strong financial results for Q1 2022, with net revenue of $706.2 million, a 46.5% increase from the previous year. Adjusted EBITDA rose 32.1% to $137.6 million. The company reported a net income of $41.8 million compared to a net loss of $4.0 million in Q1 2021. A share repurchase program for up to $200 million was authorized, reflecting confidence in the company's outlook. AdaptHealth has continued to address challenges from CPAP equipment shortages and has completed six acquisitions this year, with updated revenue guidance for 2022 between $2.840 billion and $3.040 billion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
30.01%
Tags
buybacks earnings
-
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) announced participation in a fireside chat at the BofA Securities 2022 Healthcare Conference on May 11 at 12:40 pm PT. CEO Steve Griggs and CFO Jason Clemens will lead the discussion, which can be accessed via a live webcast on AdaptHealth's website. The company is a leader in providing patient-centered healthcare-at-home solutions, serving approximately 3.8 million patients annually across the U.S. through over 750 locations. This includes services for chronic conditions like sleep apnea and diabetes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.12%
Tags
conferences
-
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) will release its Q1 2022 financial results on May 10, 2022, before market opening. A teleconference will follow at 8:30 a.m. ET for discussions regarding the results and business activities. This company is a leader in patient-centered healthcare-at-home solutions, offering products like sleep therapy equipment, diabetes supplies, and oxygen services through a network covering approximately 3.8 million patients in 47 states.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.82%
Tags
conferences earnings
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) reported exceptional results for 2021, with revenues soaring to $2.45 billion, more than double the $1.06 billion from 2020. The company serves around 3.8 million patients annually, despite facing challenges from CPAP shortages. The fourth quarter revenue reached a record $702.1 million, marking a 102% increase year-over-year. Net income for the quarter was $22.9 million, a significant recovery from a net loss of $80.5 million in Q4 2020. AdaptHealth updated its 2022 guidance, expecting revenues between $2.825 billion and $3.025 billion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.38%
Tags
-
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) announced that its CEO Steve Griggs, President Josh Parnes, and CFO Jason Clemens will participate in a fireside chat at the SVB Leerink Global Healthcare Conference on February 18 at 9:20 am ET. A live webcast and replay will be available on the Investors section of AdaptHealth's website. AdaptHealth is a leader in providing home healthcare solutions, serving approximately 3.6 million patients across 50 states with a range of medical products and services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.57%
Tags
conferences
-
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) will release its Q4 and full year 2021 financial results on February 24, 2022, before market opening. A teleconference will follow at 8:30 a.m. ET for management to discuss results and recent business activities. The company is a leader in healthcare-at-home solutions, catering to approximately 3.5 million patients annually across 700 locations. Their services include home medical equipment, diabetes supplies, oxygen therapy, and more, primarily serving Medicare, Medicaid, and commercial insurance beneficiaries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.06%
Tags
conferences earnings
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO), a leader in healthcare-at-home solutions, announced its participation in a fireside chat at the BofA Securities Home Care Conference on Monday, December 6, at 3:40 pm ET. Key executives, including Steve Griggs (CEO), Josh Parnes (President), and Jason Clemens (CFO), will represent the company. AdaptHealth serves around 3.5 million patients annually and offers a wide range of medical products and services across all 50 states, partnering with various healthcare providers to improve patient care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.15%
Tags
conferences
-
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO), a leader in healthcare-at-home solutions, announced that CFO Jason Clemens will participate in a fireside chat at the BofA Securities Leveraged Finance Conference on Thursday, December 2 at 9:00 am ET. The company provides a range of services including home medical equipment and supplies, focusing on patient-centered care. With a network of over 700 locations, AdaptHealth serves approximately 3.5 million patients across all 50 states, offering solutions for chronic conditions and various medical needs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.44%
Tags
conferences
-
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) announced that CEO Steve Griggs, President Josh Parnes, and CFO Jason Clemens will participate in a fireside chat at the Jefferies London Healthcare Conference. The presentation will be available on-demand starting Thursday, November 18, before market open, accessible via the Investors section of AdaptHealth’s website (www.adapthealth.com). AdaptHealth is a leader in providing healthcare-at-home solutions, reaching approximately 3.5 million patients annually across the U.S.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.96%
Tags
conferences
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) announced that its CEO Steve Griggs, President Josh Parnes, and CFO Jason Clemens will participate in a fireside chat at the Stifel 2021 Virtual Healthcare Conference on November 17 at 1:20 pm ET. A live webcast will be available through the Investors section of AdaptHealth’s website. The company is a leader in providing patient-centered, healthcare-at-home solutions, serving approximately 3.5 million patients annually across 716 locations in 47 states with a full suite of medical products.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.87%
Tags
conferences

FAQ

What is the current stock price of Adapthealth (AHCO)?

The current stock price of Adapthealth (AHCO) is $6.19 as of September 9, 2026.

What is the market cap of Adapthealth (AHCO)?

The market cap of Adapthealth (AHCO) is approximately 825.8M.